Guidelines and Safety Considerations in the Laboratory Diagnosis of SARS-CoV-2 Infection: A Prerequisite Study for Health Professionals.

Asrani, Purva; Hussain, Afzal; Nasreen, Khalida; AlAjmi, Mohamed Fahad; Amir, Samira; Sohal, Sukhwinder Singh; Hassan, Md Imtaiyaz

Asrani, Purva; Hussain, Afzal; Nasreen, Khalida; AlAjmi, Mohamed Fahad; Amir, Samira; Sohal, Sukhwinder Singh; Hassan, Md Imtaiyaz.

Afiliação

Asrani P; Molecular Biology and Biotechnology, ICAR- National Institute for Plant Biotechnology, New Delhi, 110012, India.
Hussain A; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Nasreen K; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.
AlAjmi MF; Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Kingdom of Saudi Arabia.
Amir S; Department of Chemistry, College of Science and General Studies, Alfaisal University, Riyadh, Kingdom of Saudi Arabia.
Sohal SS; Respiratory Translational Research Group, Department of Laboratory Medicine, School of Health Sciences, College of Health and Medicine, University of Tasmania, Launceston, Tasmania, Australia.
Hassan MI; Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, 110025, India.

Risk Manag Healthc Policy ; 14: 379-389, 2021.

Article em En | MEDLINE | ID: mdl-33568956

Palavras-chave

COVID-19; SARS-COV-2; diagnosis guidelines; safety consideration; specimen collection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Guideline / Screening_studies Idioma: En Revista: Risk Manag Healthc Policy Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google